Crossmark

CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity

Crossref DOI link: https://doi.org/10.1007/s00018-022-04187-4

Published Online: 2022-02-25

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Losenkova, Karolina

Takeda, Akira

Ragauskas, Symantas

Cerrada-Gimenez, Marc

Vähätupa, Maria

Kaja, Simon

Paul, Marius L.

Schmies, Constanze C.

Rolshoven, Georg

Müller, Christa E.

Sandholm, Jouko

Jalkanen, Sirpa

Kalesnykas, Giedrius

Yegutkin, Gennady G. https://orcid.org/0000-0001-6684-7982
Funding

Funding for this research was provided by:

Academy of Finland (332589)

Orion Research Foundation sr

Ida Montinin Säätiö

University of Turku (UTU) including Turku University Central Hospital
License Information

Text and Data Mining valid from 2022-02-25

Version of Record valid from 2022-02-25
More Information

Article History

Received: 25 July 2021

Revised: 28 January 2022

Accepted: 4 February 2022

First Online: 25 February 2022

Declarations

:

: The authors disclose no conflicts of interests.

: The experimental procedures were reviewed by the local Ethics Committee on Animal Experimentation of the University of Turku and approved by the Provincial State Office of Western Finland with the license ID ESAVI/5762/04.10.07/2017. For bright light-induced experimental model, the animals were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and the EC Directive 86/609/EEC for animal experiments, using protocols approved and monitored by the Animal Experiment Board of Finland (Experimentica Ltd. license ID: ESAVI-004139-2017/ESAVI-10815-2020).

: All authors have read and approved the final manuscript

Document is current

Any future updates will be listed below